List view / Grid view
17 June 2016 | By Victoria White, Digital Content Producer
Pfizer will invest more than $200 million in the development of the state-of-the-art facility that will enable the production of high-quality, complex biologics...
17 June 2016 | By Victoria White, Digital Content Producer
The KEYNOTE-024 trial investigating Keytruda in patients with previously untreated advanced non-small cell lung cancer has met its primary endpoint...
17 June 2016 | By Victoria White, Digital Content Producer
The NHS will receive a discount on the combination treatment agreed between Bristol-Myers Squibb and the Department of Health...
17 June 2016 | By Victoria White, Digital Content Producer
NICE has said it will not be able to recommend Vertex Pharmaceuticals’ Orkambi (lumacaftor-ivacaftor) for treating cystic fibrosis...
16 June 2016 | By Victoria White, Digital Content Producer
Results from a Phase I/II study of pidilizumab demonstrated potential clinical benefit in paediatric patients with diffuse intrinsic pontine glioma (DIPG)...
16 June 2016 | By Victoria White, Digital Content Producer
New data on IMAB362 provides hope for a subset of gastric and gastroesophageal junction adenocarcinoma patients, according to GlobalData...
The European Commission has approved Roche’s Gazyvaro (obinutuzumab) in combination with bendamustine chemotherapy followed by Gazyvaro maintenance in people with follicular lymphoma.
15 June 2016 | By Cherwell Laboratories
Cherwell process validation & environmental monitoring product range on display at APDM training course...
15 June 2016 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, is holding a series of formulation development and drug delivery seminars this June and July...
15 June 2016 | By Victoria White, Digital Content Producer
The FDA has approved a higher strength 20mg capsule of Sobi's Orfadin (nitisinone) for the treatment of Hereditary Tyrosinaemia type-1 (HT-1)...
15 June 2016 | By Victoria White, Digital Content Producer
A Phase I trial showed that APG101 was well tolerated. In addition, the study showed that APG101 efficiently stimulates erythropoiesis in these patients...
15 June 2016 | By Victoria White, Digital Content Producer
A study has found that women with ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy...
15 June 2016 | By Black Swan Analysis
The Black Swan Analysis team has substantially expanded their online database coverage of patient hospital admissions from the original 6 core markets, USA and the Top 5 EU markets, to a total of 28 markets...
15 June 2016 | By Victoria White, Digital Content Producer
The proceeds will fund Phase II development of AAI202 - a novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections...
15 June 2016 | By Victoria White, Digital Content Producer
Novartis' KAF156 is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years...
